Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers

Immunotherapy with tumor-infiltrating lymphocytes (TIL) or oncolytic adenoviruses, have shown promising results in cancer treatment, when used as separate therapies. When used in combination, the antitumor effect is synergistically potentiated due oncolytic adenovirus infection and its immune stimul...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Joao, Heiniö, Camilla, Quixabeira, Dafne, Zafar, Sadia, Clubb, James, Pakola, Santeri, Cervera-Carrascon, Victor, Havunen, Riikka, Kanerva, Anna, Hemminki, Akseli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143525/
https://www.ncbi.nlm.nih.gov/pubmed/33922052
http://dx.doi.org/10.3390/cells10050978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143525/
https://www.ncbi.nlm.nih.gov/pubmed/33922052
http://dx.doi.org/10.3390/cells10050978

Ejemplares similares